Diagnostic Test: PET-CT Imaging with [89Zr]-bevacizumab ( DrugBank: Bevacizumab )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 86 | Pulmonary arterial hypertension | 1 |
86. Pulmonary arterial hypertension
Clinical trials : 1,181 / Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03166306 (ClinicalTrials.gov) | May 1, 2018 | 9/5/2017 | Angiogenic Imaging in Pulmonary Arterial Hypertension | Angiogenic Imaging in Pulmonary Arterial Hypertension | Pulmonary Arterial Hypertension;Exercise Associated Pulmonary Arterial Hypertension | Diagnostic Test: PET-CT Imaging with [89Zr]-bevacizumab | Brigham and Women's Hospital | NULL | Completed | 18 Years | N/A | All | 5 | Phase 1/Phase 2 | United States |